Butynamine

Butynamine is a vasodilator and antianginal agent that is used in the treatment of angina pectoris. It is a member of the phenethylamine class of compounds and acts by inhibiting the action of phosphodiesterase enzymes, leading to an increase in the concentration of cyclic AMP in cells. This results in relaxation of vascular smooth muscle and dilation of coronary arteries, which increases blood flow to the heart and reduces the workload of the heart.
Pharmacology[edit]
Butynamine acts as a vasodilator by inhibiting the action of phosphodiesterase enzymes. These enzymes are responsible for breaking down cyclic AMP, a molecule that plays a crucial role in the relaxation of vascular smooth muscle. By inhibiting these enzymes, butynamine increases the concentration of cyclic AMP in cells, leading to relaxation of vascular smooth muscle and dilation of coronary arteries. This increases blood flow to the heart and reduces the workload of the heart, helping to alleviate the symptoms of angina pectoris.
Clinical Use[edit]
Butynamine is used in the treatment of angina pectoris, a condition characterized by chest pain due to reduced blood flow to the heart. By dilating the coronary arteries and increasing blood flow to the heart, butynamine helps to alleviate the symptoms of angina. It is typically used in combination with other antianginal agents to manage this condition.
Side Effects[edit]
Like all medications, butynamine can cause side effects. These may include headache, dizziness, flushing, and hypotension. In rare cases, it can cause serious side effects such as arrhythmia and myocardial infarction. Patients should be monitored closely while taking this medication.
See Also[edit]
- Vasodilator
- Antianginal agent
- Angina pectoris
- Phenethylamine
- Phosphodiesterase
- Cyclic AMP
- Vascular smooth muscle
- Coronary arteries
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
